Anders Ahlsson is the Director of Health Care in Stockholm. He is responsible for the health care system in the county, including finance and reimbursement models, quality and control of health care providers, and support to the political organization. With a background as a consultant and associate professor in cardiac surgery, Anders has contributed significantly to various European guidelines in cardiology and cardiac surgery, participating as a task force member. Currently, his primary areas of focus include leadership, strategic decision-making, and judgment. In addition to his duties in Stockholm, Anders is actively involved in national committees related to healthcare and education.

Rob Allen is the president and CEO of Intermountain Health, a leading nonprofit health system headquartered in Utah with locations in six states and operations across the western U.S. In 2023, Modern Healthcare named Rob as one of the 100 Most Influential People in Healthcare. Rob has served in executive leadership roles at Intermountain for 28 years of his 30+ year health leadership career. He is a nationally recognized leader in advancing value-based care and has multiple achievements around advancing rural health, telehealth, affordability, and continuous improvement. Prior to beginning his role as president and CEO in November 2022, Rob served as chief operating officer for five years. He was named as one of the top 25 COOs in healthcare by Modern Healthcare. He has also held CEO roles at hospitals and health systems in Wyoming, New Jersey, and Massachusetts. Rob earned a Master of Business Administration degree from Utah State University and a Bachelor of Science in operations management from Brigham Young University. He was also awarded an honorary Doctor of Science degree by Rocky Vista University. Rob’s love of healthcare began during his childhood as he was raised on a farm in rural Wyoming, where his mother served as a nurse and later as administrator at Star Valley Hospital. Rob and his wife, Becky, have three children and six grandchildren.

Medical School: Hebrew University, Hadassah Residency: Hadassah University Hospital Fellowship: Gynecologic Oncology (NYU), Jerusalem, Israel, New York University Medical Attending Physician: NYU medical Center Chairman: Dept of Gynecology, Share Zedek Medical Center President: Israeli Society of Gynecologic Oncology President: ESGO European Society of Gynecologic Oncology Editor in Chief: The International Journal of Gynecological Cancer Center.

Chairman of the Executive Board, Netherlands Cancer Institute and Antoni van Leeuwenhoek Hospital, Netherlands

Dr. Anke Diehl, M.D., M.A., is Chief Transformation Officer and Head of the Digital Transformation Unit at the University Medicine Essen (UME). As a medical doctor with broad clinical and scientific experience (neurology, psychiatry, neuroradiology and radiology), she is responsible for implementing innovative projects as part of the smart hospital’s digitization strategy. Prior to her position as Digital Change Manager of UME, she was head of the department of health care structure development in one of the subordinate divisions of the Ministry of Health NRW (LZG.NRW). The expert for digital medicine has been consortium leader of the leading edge cluster of artificial intelligence in medicine “SmartHospital.NRW“ since March 2021. She is a member of numerous committees, such as the scientific advisory board of Medizin.NRW, the board of SMITH (Smart Medical Information Technology for Healthcare/German Medical Informatics Initiative) and the medical advisory board to accompany the development of a telematics infrastructure for healthcare in NRW. End of 2021, Dr. Diehl was appointed by the German Federal Ministry of Health and the Gematik to the 7-member National Expert Panel “Interop Council” and won the „Medical Woman of the Year 2021“ award (German Medical Awards). She is also member of the Expert Panel „Ausschuss Digitalisierung in der Gesundheitsversorgung“ of the German Federal Medical Association.

Alan J. Forster MD, FRCPC, MSc is the Vice President, Innovation, Transformation, and Clinical Performance at the McGill University Health Center and the McGill University Professor for Health Innovation. His focus is enabling teams to create higher value health care – in which patient outcomes are realized and health system costs are lowered. Over his career, he has led local, national, and international efforts to improve healthcare quality. His research programs have contributed to over 240 publications in peer review journals and innumerable advances in quality. Lasting contributions include his impact on the development of a model for learning health systems leveraging healthcare data. In recognition of his contributions, he was listed as one of Canada’s top 10 healthcare power brokers by Maclean’s Magazine in April 2023 and named to the International Society for Quality in Healthcare’s International Academy for Quality and Safety in Healthcare in July 2023.

Dr. Halamka is an emergency medicine physician, medical informatics expert and president of the Mayo Clinic Platform, which is focused on transforming health care by leveraging artificial intelligence, connected health care devices and a network of partners. Dr. Halamka has been developing and implementing health care information strategy and policy for more than 40 years. Previously, he was executive director of the Health Technology Exploration Center for Beth Israel Lahey Health, chief information officer at Beth Israel Deaconess Medical Center, and International Healthcare Innovation Professor at Harvard Medical School. He is a member of the National Academy of Medicine.

CEO, Sahlgrenska University Hospital, Sweden

Julian joined NHS Providers as chief executive in February 2023, having been chief executive of Leeds Teaching Hospitals since 2013. NHS Providers is the membership organisation for the NHS hospital, mental health, community and ambulance services that treat patients and service users in the NHS. We help those NHS foundation trusts and trusts to deliver high-quality, patient-focused care by enabling them to learn from each other, acting as their public voice and helping shape the system in which they operate. NHS Providers has all trusts in England in voluntary membership, collectively accounting for £115bn of annual expenditure and employing 1.4 million people. During his decade of service at Leeds, Julian led a major programme of culture change and staff engagement to deliver improved quality, operational and financial performance. In 2019 Julian was asked by Baroness Dido Harding, Chair of NHS Improvement, to be the executive lead for the interim NHS People Plan. He previously worked as managing director of NHS Improving Quality – a national organisation set up to drive change and improvement across the NHS. Julian’s career in the NHS began as a general management trainee working in the North East of England. Following his training, he worked in a number of NHS management posts at hospital, health authority and regional level. His first board director appointment was at North Tees and Hartlepool NHS Trust, where he was responsible for planning, operations and strategy. Julian led Tameside and Glossop Primary Care Trust (PCT) as chief executive for three years, where he took it to three-star status, developed new Primary Care Centres and managed the PCT’s involvement in the Shipman Inquiry. From 2005, Julian was chief executive of Blackpool, Fylde and Wyre Hospitals NHS Foundation Trust, seeing the trust transform and go on to achieve major financial turnaround, secure Foundation Trust status and become one of the first trusts in the country to meet 18-week targets. In addition, Julian chaired the North West Leadership Academy. Julian was appointed chief executive of University Hospital of South Manchester NHS Foundation Trust in June 2009 and led a major turnaround in MRSA reduction, A&E and 18 week performance. He also introduced a major programme of cultural change to improve patient experience and outcomes. Julian was awarded Knight Bachelor for services to healthcare in the 2022 Queen’s Birthday Honours.

Regional Leader for Healthcare, Health Providers and Payors, EMEA, Microsoft, Israel

Anwer is a healthcare and life sciences technology consulting leader with a track record of launching and growing large-scale technology-based practices and market offerings across healthcare ecosystems. He helps organizations to capitalize on emerging and disruptive technologies, cloud-based/digital solutions, and agile consumption and delivery models.

As Global Healthcare Sector Technology Leader for KPMG International, he leads and collaborates with a global network that creates digital solutions to help address critical challenges and support transformation in healthcare organizations in agile, secure, and scalable ways.

As Partner, Advisory, Customer and Operations, Health and Government, for KPMG in the U.S., Anwer is focused on developing IT-enabled solutions that help his clients to achieve meaningful clinical and operational transformation.

Anwer holds several registered patents in the United States in the areas of health data management and advanced analytics. He is also a frequently published author and speaker on pressing technology topics.

Dr. Klasko is an author, an entrepreneur and a believer in the creative and optimistic transformation of healthcare and higher education. He has been a health system CEO, a university president, and a dean of two medical colleges. Currently he is pursuing his passion to bridge academic health centers with the emerging world of generative AI, digital medicine and innovation. As President of Thomas Jefferson University, he directed a merger between an almost two century old health science university and a nationally ranked university for design and architecture. That merger was heralded by the Chronicle of Higher Education as one of the “few successful mergers between academic entities.” As CEO of Jefferson Health, he presided over the growth of the system from $1.5 billion to $9 billion including the acquisition of Health Partners Plan, making Jefferson the first integrated delivery and financial system in Philadelphia history and the largest health system in Philadelphia. This included a first of its kind digital “health at any address” partnership between Jefferson and leading health venture capital firms such as General Catalyst, a16z and Oak HC. He has been a board member and advisor to several AI behavioral health entities and led the Forbes Health Summit this year on the ethical and regulatory “unintended consequences” of generative AI. His most recent book, Feelin’ Alright: How the Message in the Music Can Make Healthcare Healthier uses music and creativity to tackle the biggest issues in healthcare His fifth book (with Hemant Taneja of General Catalyst) in 2021, UnHealthcare: A Manifesto for Health Assurance has become the manual for both founders and health system CEOs for merging the venture capital world with the traditional healthcare ecosystem. Dr. Klasko serves as Executive in Residence at General Catalyst, North American ambassador for Sheba Medical Center in Israel, and as CMO and Operating Partner of Abundant Partners. He is the lead independent director for Teleflex (TFX:NYSE), a multi-billion dollar medical device company. In 2022, President Biden appointed him to the National Board of Education Sciences. He serves as a member of the Founders Circle for BrightEdge, a unique impact investing arm of the American Cancer Society. Dr. Klasko is also the board chair of Opera Philadelphia and a trustee of Rosalind Franklin University and Chicago Medical School. Over the past five years he has been awarded by Fast Company as one of the “top 25 most creative people in business,” by Modern Healthcare as the “#2 most influential person in healthcare” and by Ernst and Young as the “entrepreneur of the year.” He lives in Miami and New York with his wife Colleen Wyse, a commercial model and former fashion executive with senior positions in Vogue, W and Glamour.

Ernst Kuipers has extensive experience in healthcare, medical research, and government. He will serve as Vice-President Research for Nanyang Technological University in Singapore. Ernst previously served as Minister of Health, Welfare and Sport of The Netherlands. He focused on a broad integrated care agenda to improve access, clinical outcomes, and workforce satisfaction. Before, Ernst long served Erasmus MC University Medical Center in Rotterdam, the Netherlands as CEO, Professor of Medicine and Department Chair. As CEO, he led the transformation to a new ‘smart’ hospital that forms part of the European University Hospital Alliance. Ernst was a Member of the Governing Board of the National University Health System in Singapore and Board member of Curacao Medical Center. He further acted as Chair of the Dutch National Emergency Medicine Network, which played a major role during the covid pandemic. Ernst earned a medical degree, and then completed training in Internal Medicine and Gastroenterology in the Netherlands. He subsequently worked at Vanderbilt University Medical Center, Nashville, TN, and then joined Erasmus MC.

Chief Executive Officer, Singapore General Hospital, Singapore

Marcel Levi is president of the Dutch Research Council and currently vice-president of Science Europe. Previously he was chief executive of the Academic Medical Center in Amsterdam where he initiated the merger with the Free University Medical Center to Amsterdam University Medical Center. Thereafter he was chief executive of University College London Hospitals in the UK. He is professor of Medicine at Amsterdam University Medical Center/University of Amsterdam and University College London and a specialist in Internal Medicine and Haematology. Earlier he worked at the University of Perugia (Italy), in Oxford (UK) and at the Center for Transgene Technology and Genetherapy of the University of Leuven (Belgium). He has published over 800 research articles in international journals and is (associate) editor of various scientific journals. He is currently chairman or board member of several national and international research and health care organisations and charities. He is a member of the Royal Netherlands Academy of Science and Fellow of the Royal College of Physicians. He is editor of various scientific journals and author of many popular/scientific/educational books and columns.

Christoph A. Meier is Director of the Department of Internal Medicine at the University Hospital Zürich and holds a faculty appointment at the University of Geneva. He has a longstanding interest in the evaluation and improvement of quality in health care and is/was serving among others on the Expert Board for Newseek’s Best Hospitals of the World, the Swiss Medical Board for HTA and the Swiss Federal Quality Commission.
Prior to his current role, he was the Chief Medical Officer and deputy CEO at the University Hospital Basel, where he implemented the principles of value-based health care and PROMs as key tools for quality and performance management. Previously, held the position as the Chief of Medicine at the Triemli Hospital in Zürich and was heading the Clinical and Molecularl Endocrinology Unit at the University Hospital Geneva, Switzerland.
He received his Medical Degree from the University of Basel, Switzerland and holds Board Certifications in Internal Medicine and Endocrinology & Diabetology and worked at the University Hospital Geneva, the National Institutes of Health (USA), the Brigham and Women’s Hospital and the Massachusetts General in Boston.

Dr. Itamar Offer is a Healthcare management professional (Medical doctor) with 25 years of experience at senior positions in hospitals and community healthcare. Of those 8 years in the Israeli Public Healthcare, 4 years in India’s private healthcare and 5 years as CEO at Herzliya Medical Center. Most recently, Dr. Offer was the CEO & Chairman of Sabar Health Ltd, Israel’s largest “Hospitalization at Home” organization. Dr. Offer is the Founder and Co-Chair of the World Hospital at Home Congress and Community. Itamar has an MD degree from Tel-Aviv University, and Masters in Public Administration (MPA) degree from Harvard Kennedy School. He is a specialist in Pediatrics and in Healthcare Management.

Umang has a deep understanding of the nuances between AI and healthcare, having worked on the frontline of digital health innovations. With hands-on experience spanning both the commercial and public sectors of healthcare, he’s keenly aware of the potential that AI offers in enhancing patient care and streamlining processes. An NHS Leadership Academy Fellow and active clinician at Frimley Health, Umang has also contributed to Babylon Health’s pioneering efforts in AI health services. Today, as the Chief Clinical Information Officer for Microsoft UK, he combines his clinical insights with technological ability to ensure that AI tools are both advanced and applicable in real-world healthcare settings.

As Global Head of Healthcare, Anna leads the KPMG healthcare network of 5,000 professionals who provide Audit, Tax and Advisory services to healthcare organizations in more than 70 countries and territories around the world. Anna is a trusted advisor to health leaders ranging from ministers of health, hospital CEOs and executives of payor organizations across six continents. She draws on more than 30 years of experience in diverse senior managerial, board, and consultancy roles in the sector. She understands the complex nature of the sector and brings not only a bold vision for the future of health but also the experience to execute on transformation initiatives. Anna is the author of several KPMG International publications on topics that include future scenario’s for healthcare systems, organizational transformation, health equity, sustainability and resilience, value-based healthcare, out of hospital care provision, and technology-enabled care delivery systems. She is a well-regarded keynote speaker at international events covering topics that include healthcare system effectiveness and resilience, digital transformation and health equity. Anna sits on the Steering Committee for the Partnership for Health System Sustainability and Resilience, a global collaboration between the World Economic Forum, the London School of Economics, AstraZeneca, Royal Philips, KPMG, Apollo Hospitals and the Center for Asia-Pacific Resilience and Innovation. Prior to her appointment as Global Head in 2020, Anna was Head of Healthcare for KPMG in the Netherlands, where she founded and grew the firm’s healthcare advisory business. In this role, she supervised a number of successful national and regional transformation programs based on design and implementation of new service delivery, reimbursement and governance models and physical infrastructures. Anna was also global lead for KPMG’s Care System Redesign proposition group, in this capacity she worked extensively with clients to transform and help futureproof care systems. Before joining KPMG in 2011, Anna held senior-level positions at several hospitals and academic health sciences centers, where she led and executed transformations. As CEO of the Dutch Diagnosis Related-Groups (DRGs) and Pricing Office, Anna was a major force behind the adoption of DRG systems for providers and the introduction of a new national healthcare payment system. Anna has a PhD in Economic Sciences from Erasmus University Rotterdam. She is fluent in English, French, German and Dutch.

Having experienced her first symptoms of Parkinson’s disease at age 13, Sara Riggare now, 40 years later, utilizes her patient experiences and her academic training to conduct research that is truly patient-centered. She has made it her mission to bring patients, researchers, healthcare, industry, and policymakers closer together to improve health for all. In 2022, Sara became the first person in the world to earn a PhD with a thesis on personal science. She is a well-known patient leader, highly appreciated speaker, and was named Swede of the year in medicine 2018. Sara advises, among others, the British Medical Journal, the Swedish Medical Products Agency, the Swedish National Board for Health and Welfare, and the Swedish Governmental Agency on Innovation Systems.

Ido is a partner at KPMG and leads the digital transformation and artificial intelligence departments, where major technological projects are carried out in Israel and abroad under his management. Over the years, Ido has led the largest projects in the world that dealt with the implementation of edge technologies, those that touch the entire width of an organization and change the way it is conducted. Before KPMG, Ido led the field of artificial intelligence at IBM where he dealt with the technology itself and saw the needs of the customers in front of the technological capabilities. Ido started his career as a developer and led development teams at Intel.

Dr. Eran Rotman M.H.A M.D is a Family physician, who served throughout the years in both community & hospital management leading roles. He was the General Director of Beilinson hospital during the COVID pandemic. He is now the Deputy CEO & head of Health division, Maccabi Health Services, in charge of the entire community medical services 0f 2.7 M patients. He is an expert in Community- Hospital Continuity of care, Home Hospitalization and Public health Management during crisis.

As senior vice president of community and population health, Debbie Salas-Lopez, MD, MPH, oversees Northwell Health’s community and public health strategy, including community health equity, community relations, strategic community partnerships, corporate social responsibility, and the Community Health Needs Assessment. Dr. Salas-Lopez’s leadership was critical during the COVID-19 pandemic. She and her team partnered with many community and faith-based leaders to identify their most-pressing needs. This became the catalyst for the creation of Northwell’s Health Equity Taskforce composed of more than 100 community, faith, and tribal nation leaders that today continue to work on equity and social issues that impact health. Dr. Salas-Lopez joined Northwell in 2019 as senior vice president for transformation, responsible for system value-based initiatives that improve health and care delivery. She assumed her leadership role after serving as the chief transformation officer at Lehigh Valley Health Network, where she led strategy and oversaw a unique and broad portfolio, including community-based and population health initiatives, telehealth, connected care, and innovation, strategic partnerships, and operational redesigning of the clinical delivery system. Dr. Salas-Lopez is a nationally recognized speaker and educator on women leaders, healthcare disparities and equity in care, cultural awareness and language-appropriate services, and the impact of social and economic factors on health. In 2021, Modern Healthcare named her to its annual Top 25 Women Leaders as a “Woman to Watch.” She also received the 2021 Tribute to Excellence in Health Care award from the United Hospital Fund. Dr. Salas-Lopez was recognized in 2021 by the Hospital Association of New York State with a Community Health Improvement Award. She also has earned a Hispanic Chamber of Commerce Leadership Award, the Long Island Coalition for Homeless Key of Excellence Award and the 2021 Empire Whole Health Heroes Award.

Melvin Samsom has a distinguished career, both as a gastroenterologist, a scientist and as an administrator. Currently, he serves as a non-executive director of Bupa, a global health insurance and healthcare provider spanning five continents. Additionally, Melvin chairs the supervisory committee overseeing the Reorganization of the Academic Care Landscape for the Dutch Ministry of Health and holds the position of Chair of the supervisory board at the Oncode Institute. He also serves as a Senior National and International Advisor for KPMG Health. Melvin has been honored with a prestigious personal grant from the Royal Netherlands Academy of Arts and Sciences. His research experience extends to institutions such as the Royal Adelaide Hospital in Australia, the Mayo Clinic in the United States, and the University Medical Center Utrecht in the Netherlands. Previously, Melvin Samsom served as the Chief Executive Officer of Karolinska University Hospital in Sweden, where his leadership ushered in a groundbreaking operating model centered around the patient journey. Under his guidance, the commissioning of one of the largest and most technologically advanced hospital buildings was successfully completed. Prior to his tenure in Sweden, Melvin held the positions of CEO and CMO at the Radboud University Medical Center in the Netherlands, orchestrating a significant organizational turnaround. More recently, he crafted the Health, Wellbeing, and Biotech strategy for NEOM, aspiring to establish the healthiest place in the world. This strategy emphasizes proactive prevention and world-class treatment of diseases. Melvin has also contributed as a Senior International Advisor to the Health Holding Company and has been a member of several Health Clusters in Saudi Arabia.

Arthur Schellekens is chief executive officer of the Dutch Patient Federation, an advocacy organization with circa 90 professionals representing more than 200 patient organizations. The Federation is committed to all people requiring healthcare, now and in the future. It gives patients a voice: in the consulting room, in policy making, in research activities and in the politics by advising, actively cocreating with stakeholders and by lobbying activities. By gathering and analyzing individual experiences of patients, the Dutch Patient Federation is bridging the gap between patients’ needs and the healthcare offered. Part of this effort is to provide patients with a comprehensive, yet easy-to-understand information thereby helping them make informed choices. Arthur Schellekens (1970) is an experienced and dedicated officer with expertise in managing non-profit organizations with a bit of a business slant. He has been director of the Dutch Association of Youth Care and Child Protective Services, the Dutch Association of Public Libraries and the Royal Dutch Association of Realtors (amongst others). Arthur has a Master’s degree in Public Administration. He is a practical person, realizing that only collaboration and co-creation can lead to truly meaningful and long-term results.

Munjal Shah is the co-founder and CEO of Hippocratic AI, a startup building the first safety-focused large language model (LLM) for healthcare. The company is on a mission to dramatically improve healthcare access, equity and outcomes through the use of generative AI. Munjal is a serial entrepreneur, startup adviser, and investor. He was co-founder and CEO of an AI company that was acquired by Google and a marketplace management, research and analytics company eventually sold to Alibaba. He graduated from Stanford with a Masters in Computer Science, focused on AI. Prior to Hippocratic AI, Munjal spent 10 years as co-founder and CEO of a healthcare startup leveraging AI to analyze health records to help seniors select the best Medicare Advantage plan.

Managing Director, Health City Cayman Islands, Cayman Islands

Thea Stein is the Chief Executive of the Nuffield Trust. She took up the post in September 2023. Thea was previously Chief Executive at Leeds Community Healthcare NHS Trust, and before then Chief Executive of Carers Trust, Yorkshire Forward and North East Leeds Primary Care Trust. Thea has also held a number of non-executive roles in housing organisations and academia. Thea was a trustee of the Nuffield Trust between 2019 and 2023.

Elad Walach is a co-founder and CEO of Aidoc. He is an expert in AI with visionary business insights in the healthcare space. Since establishing Aidoc in early 2016, Elad led the company through 4 investment rounds bringing the total investment to $250M, drove the commercial availability of 20 product lines, created an install base of over 1,000 global hospitals while growing the company to over 400 employees. Elad began his career in the elite Israeli Defense Force technology program “Talpiot”. He led AI research in the Israeli Air Force where he initiated and managed several teams focused on machine learning and computer vision projects.

Chief Innovation Officer and Chief Transformation Officer, Sheba Medical Center, Israel